The PepT1 transporter adds another dimension: KPV's anti-inflammatory mechanism is delivered directly into inflamed gut cells via a transporter that is selectively upregulated in diseased tissue
It has been studied for its potential to regulate gene expression in neurons, supporting cognitive performance, brain cell protection, and overall neural health
7 , 8 The main reported symptoms are shortness of breath, chest pain, headaches, neurocognitive difficulties, depression and other mental health conditions, muscle pains and weakness, gastrointestinal disorders, rashes, metabolic disruption, and thromboembolic conditions
Some report vivid dreams, which may indicate deeper sleep stages